John Flavin
Fundador en PYXIS ONCOLOGY, INC. .
Fortuna: 1 M $ al 31/05/2024
Cargos activos de John Flavin
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PYXIS ONCOLOGY, INC. | Fundador | 11/06/2018 | - |
Presidente | 11/06/2018 | - | |
Independent Dir/Board Member | 11/12/2019 | - | |
Director/Miembro de la Junta | 11/12/2019 | - | |
Flavin Ventures LLC | Corporate Officer/Principal | 04/01/2010 | - |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Director Ejecutivo | 01/03/2022 | - |
Fundador | 01/03/2020 | - | |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Presidente | - | - |
Historial de carrera de John Flavin
Antiguos cargos conocidos de John Flavin.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Endotronix, Inc.
Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Director Financiero/CFO | 01/04/2018 | 01/02/2020 |
ADVANCED LIFE SCIENCES HOLDINGS, INC. | Director/Miembro de la Junta | 01/06/2002 | 05/05/2011 |
Director Financiero/CFO | 05/05/2011 | 05/05/2011 | |
Presidente | - | 05/05/2011 | |
Secretario Corporativo | 05/05/2011 | 05/05/2011 | |
MediChem Life Sciences, Inc.
MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Director de Operaciones | 01/05/2000 | 01/05/2002 |
Director Financiero/CFO | 01/01/1991 | 01/05/2000 | |
Presidente | 01/01/1991 | 01/05/2000 | |
Advanced X-Ray Analytical Services, Inc. | Presidente | - | - |
ThermoGen, Inc.
ThermoGen, Inc. Medical SpecialtiesHealth Technology ThermoGen, Inc. develops biocatalysts for pharmaceutical production. The company was headquartered in Chicago, IL. | Presidente | - | - |
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
Formación de John Flavin.
Lewis University | Masters Business Admin |
Marquette University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 13 |
Operativa
President | 5 |
Director of Finance/CFO | 3 |
Director/Board Member | 2 |
Sectorial
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PYXIS ONCOLOGY, INC. | Health Technology |
Empresas privadas | 9 |
---|---|
MediChem Life Sciences, Inc.
MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Commercial Services |
Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences Holdings, Inc. BiotechnologyHealth Technology Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL. | Health Technology |
Endotronix, Inc.
Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Health Technology |
Emerald BioStructures, Inc.
Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beryllium LLC, Emerald BioStructures, Inc. is a company that offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. The company is based in Bainbridge Island, WA. The company was founded by Lance K. Stewart. Emerald BioStructures was acquired by MediChem Research, Inc. on May 31, 2000. | Commercial Services |
ThermoGen, Inc.
ThermoGen, Inc. Medical SpecialtiesHealth Technology ThermoGen, Inc. develops biocatalysts for pharmaceutical production. The company was headquartered in Chicago, IL. | Health Technology |
Flavin Ventures LLC | |
Advanced X-Ray Analytical Services, Inc. | |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Finance |
- Bolsa de valores
- Insiders
- John Flavin
- Experiencia